CV Lattes
ORCID
Abstract
Introduction: Triple negative breast carcinomas (TNBC), although sensitive to neoadjuvant chemotherapy (NACT), have higher rates of early recurrence and worse prognosis when compared to other BC subtypes. They do not express estrogen, progesterone and human epidermal growth factor 2 (HER2) receptors. However, TNBCs include different diseases, with different histologies, tumor microenviron…